Replies to post #22527 on Ocata Therapeutics Inc fka OCAT

[louisa]

Of course, not fully awake yet and I was remembering this statement and had a brain freeze moment.
From the PR:

“We are pleased that the FDA has, for the first time, granted orphan drug status for the use of an embryonic stem cell derived therapy in treating an unmet medical need,” said Edmund Mickunas, Vice President Regulatory. “We believe that our terminally differentiated RPE cells represent a promising treatment for patients with SMD and expect to be in a position to accelerate clinical development and hopefully make RPE cellular therapy available to the majority of patients sooner.”